ESPR Other Income/Expenses (Net)
Esperion Therapeutics Inc · Other Income/Expenses (Net)
ESPR Other Income/Expenses (Net)
Latest reported-$81.37Mperiod ending
ESPR TTM Other Income/Expenses (Net) (-$4.02M → -$81.37M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
ESPR other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| -81,370,000 | |
| -81,114,000 | |
| -76,451,000 | |
| -68,575,000 | |
| -113,259,000 | |
| -106,147,000 | |
| -103,226,000 | |
| -103,445,000 | |
| -51,818,000 | |
| -53,685,000 | |
| -52,682,000 | |
| -52,459,000 | |
| -53,530,000 | |
| -54,158,000 | |
| -50,675,000 | |
| -50,822,000 | |
| -48,009,000 | |
| -42,378,000 | |
| -41,794,000 | |
| -33,039,000 | |
| -26,463,000 | |
| -22,155,000 | |
| -16,230,000 | |
| -13,953,000 | |
| -8,317,000 | |
| -4,064,000 | |
| -472,000 | |
| 2,788,000 | |
| 2,461,000 | |
| 2,775,000 | |
| 2,970,000 | |
| 2,837,000 | |
| 2,410,000 | |
| 1,994,000 | |
| 1,518,000 | |
| 1,310,000 | |
| 1,283,000 | |
| 1,172,000 | |
| 955,000 | |
| 763,000 | |
| 534,000 | |
| 256,000 | |
| 67,000 | |
| -157,000 | |
| -208,000 | |
| -151,000 | |
| -27,000 | |
| 248,000 | |
| -2,417,000 | |
| -3,328,000 | |
| -3,990,309 | |
| -4,520,334 | |
| -2,173,607 | |
| -1,537,976 | |
| -1,264,667 | |
| -1,505,642 | |
| -1,520,369 | |
| -1,683,000 | |
| -1,228,000 | |
| -1,144,000 | |
| -780,000 | |
| -51,000 | |
| 62,000 | |
| 3,192,000 | |
| 6,225,000 | |
| 4,863,000 | |
| 1,208,000 | |
| -1,095,000 | |
| -4,022,392 |